Financials Shandong Weigao Orthopaedic Device Co., Ltd

Equities

688161

CNE1000050W9

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
24.69 CNY +1.11% Intraday chart for Shandong Weigao Orthopaedic Device Co., Ltd +7.82% -40.43%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 25,488 20,876 16,580 9,853 - -
Enterprise Value (EV) 1 25,488 20,876 16,580 9,853 9,853 9,853
P/E ratio 35 x 38.4 x 148 x 39.8 x 30.1 x 25.2 x
Yield - 0.79% 0.29% 0.49% 1.01% 1.17%
Capitalization / Revenue 11.8 x 11.3 x 12.9 x 6.56 x 5.54 x 4.79 x
EV / Revenue 11.8 x 11.3 x 12.9 x 6.56 x 5.54 x 4.79 x
EV / EBITDA 29,645,138 x 28,328,876 x - - - -
EV / FCF - 62.1 x 211 x 43.8 x 28.3 x 18.7 x
FCF Yield - 1.61% 0.47% 2.28% 3.53% 5.35%
Price to Book 5.61 x 4.29 x 4.29 x 2.43 x 2.3 x 2.16 x
Nbr of stocks (in thousands) 400,000 400,000 400,000 399,083 - -
Reference price 2 63.72 52.19 41.45 24.69 24.69 24.69
Announcement Date 2/22/22 2/27/23 2/29/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 2,154 1,848 1,284 1,502 1,779 2,055
EBITDA - 859.8 736.9 - - - -
EBIT 1 - 811.5 638.6 130.9 292 384 456
Operating Margin - 37.68% 34.56% 10.2% 19.44% 21.59% 22.19%
Earnings before Tax (EBT) 1 - 809.9 638.4 131.6 292 385 457
Net income 1 558.4 690.3 544.2 112.3 250 328 390
Net margin - 32.05% 29.45% 8.75% 16.64% 18.44% 18.98%
EPS 2 1.560 1.820 1.360 0.2800 0.6200 0.8200 0.9800
Free Cash Flow 1 - - 336.2 78.55 225 348 527
FCF margin - - 18.19% 6.12% 14.98% 19.56% 25.64%
FCF Conversion (EBITDA) - - 45.62% - - - -
FCF Conversion (Net income) - - 61.78% 69.94% 90% 106.1% 135.13%
Dividend per Share 2 - - 0.4100 0.1200 0.1200 0.2500 0.2900
Announcement Date 4/23/21 2/22/22 2/27/23 2/29/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - 336 78.5 225 348 527
ROE (net income / shareholders' equity) - 20.1% 11.7% 2.81% 6.1% 7.6% 8.5%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - 11.40 12.20 9.670 10.20 10.80 11.40
Cash Flow per Share - 1.780 1.110 - - - -
Capex 1 - - 107 40.9 51 41 33
Capex / Sales - - 5.81% 3.19% 3.4% 2.3% 1.61%
Announcement Date 4/23/21 2/22/22 2/27/23 2/29/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
24.69
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688161 Stock
  4. Financials Shandong Weigao Orthopaedic Device Co., Ltd